Cargando…

Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B

OBJECTIVE: To detect expression and phosphorylation level of macrophage migration inhibitor (MIF) and extracellular-regulated kinases 1 and 2 (ERK1/2) in hepatitis B-induced liver cirrhosis (HBILC) and hepatocellular carcinoma (HCC) with a background of HBILC and analyze the correlation of MIF and E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Dong, Li, Bin, Wang, Jun-Ke, Wang, Pan, Li, Chu-Yi, Lu, Li-Xia, Tian, Wen-Yan, Yu, Xiao-Hui, Zhang, Jiu-Cong, Zheng, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145491/ https://www.ncbi.nlm.nih.gov/pubmed/37124953 http://dx.doi.org/10.2147/PGPM.S398976

Ejemplares similares

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Correlation between CT features and liver function and p53 expression in hepatitis, cirrhosis and hepatocellular carcinoma
por: Hu, Yahui, et al.
Publicado: (2018)

Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis
por: Ren, Meixin, et al.
Publicado: (2019)

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma
por: Xu, Juan, et al.
Publicado: (2021)

Correlations of MIF polymorphism and serum levels of MIF with glucocorticoid sensitivity of sudden sensorineural hearing loss
por: Zhu, Wen-Yan, et al.
Publicado: (2019)

Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling
por: Lin, Shuai, et al.
Publicado: (2022)

Unusual Ileocecal Ulcers after Liver Transplantation for Hepatitis B Cirrhosis and Hepatocellular Carcinoma
por: He, Kang, et al.
Publicado: (2022)

MIF is a critical regulator of mononuclear phagocytic infiltration in hepatocellular carcinoma
por: Liao, Yunxi, et al.
Publicado: (2023)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
por: Dong, Wei, et al.
Publicado: (2020)

The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
por: Zhang, Qing, et al.
Publicado: (2012)

MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis
por: Hu, Chun-Ting, et al.
Publicado: (2015)

Isopsoralen ameliorates rheumatoid arthritis by targeting MIF
por: Han, Yi, et al.
Publicado: (2021)

Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Mai, Rong-yun, et al.
Publicado: (2020)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

A novel index for staging hepatitis B related liver cirrhosis in patients with hepatocellular carcinoma
por: Wu, Juanhua, et al.
Publicado: (2021)

Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma
por: Jiang, Chen Hao, et al.
Publicado: (2020)

Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
por: Xun, Zhen, et al.
Publicado: (2023)

Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis
por: Ma, Li-Na, et al.
Publicado: (2017)

Hepatic adenomatosis in liver cirrhosis
por: Gordic, Sonja, et al.
Publicado: (2017)

Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis
por: Xia, Xiaoxue, et al.
Publicado: (2018)

LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis
por: Pan, Hong Y., et al.
Publicado: (2021)

Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis
por: Poulsen, Kyle L., et al.
Publicado: (2021)

Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study
por: Wang, Zhi, et al.
Publicado: (2015)

Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
por: Shi, Ke, et al.
Publicado: (2023)

Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

Hepatocellular carcinoma in the absence of liver cirrhosis in a treated hepatitis C virus patient
por: Al Nozha, Omar M., et al.
Publicado: (2009)

The Expression of Embryonic Liver Development Genes in Hepatitis C Induced Cirrhosis and Hepatocellular Carcinoma
por: Behnke, Martha, et al.
Publicado: (2012)

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma
por: Nomair, Azhar Mohamed, et al.
Publicado: (2019)

The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis
por: Abdelhamed, Walaa, et al.
Publicado: (2023)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
por: Zheng, Ruipeng, et al.
Publicado: (2020)

Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
por: Lim, Jihye, et al.
Publicado: (2021)

Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis
por: Shi, Ke, et al.
Publicado: (2020)

Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
por: Li, Man-Yu, et al.
Publicado: (2023)

Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus-positive cirrhosis
por: Chen, Qi-Feng, et al.
Publicado: (2018)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology
por: Zhao, Dandan, et al.
Publicado: (2022)

Endogenous carbon monoxide downregulates hepatic cystathionine-γ-lyase in rats with liver cirrhosis
por: GUO, SHI-BIN, et al.
Publicado: (2015)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8sn2u6pm4p62v7gpj8mff3h565